$1.15B
$22,000
0.0% of portfolio
501
Q3 2024
Added 0.2%
$0
$1,000
0.0% of portfolio
37
Q4 2022
Reduced 92.11%
$0
$12,000
0.0% of portfolio
81
Q3 2024
Reduced 57.14%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 99.0%
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.41B
$28,000
0.0% of portfolio
2,785
Q3 2024
Added 34.15%
$0
$88,000
0.0% of portfolio
3,879
Q1 2024
Added 0.18%
-
$0
0.0% of portfolio
-
Q2 2023
New
$414M
$23,000
0.0% of portfolio
939
Q3 2024
Reduced 6.1%
$558M
$0
0.0% of portfolio
17
Q3 2024
Reduced 98.81%
$6.91B
$55,000
0.0% of portfolio
2,866
Q3 2024
Added 5.64%
$3.82B
$403,000
0.0% of portfolio
10,964
Q3 2024
Added 0.68%
Lithium Americas Argentina C
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 15.45%
$1.38B
$36,000
0.0% of portfolio
2,000
Q1 2024
New
$628M
$0
0.0% of portfolio
7
Q3 2024
New
$79.5B
$3.2 Million
0.0% of portfolio
25,529
Q3 2024
Reduced 6.7%
$5.91B
$104,000
0.0% of portfolio
2,427
Q3 2024
Reduced 1.58%
$4.49B
$45,000
0.0% of portfolio
3,340
Q3 2024
New
$384M
$0
0.0% of portfolio
1
Q3 2024
New
$1.24B
$43,000
0.0% of portfolio
11,724
Q3 2024
Reduced 3.11%
$3.72B
$1.35 Million
0.0% of portfolio
44,379
Q3 2024
Reduced 0.72%
$1.4B
$0
0.0% of portfolio
1
Q3 2024
New
$1.98B
$0
0.0% of portfolio
20
Q2 2023
New
$7.2B
$29,000
0.0% of portfolio
528
Q3 2024
Reduced 34.0%
Rigel Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
Structure Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$6.03B
$10,000
0.0% of portfolio
555
Q4 2021
New
$3.66B
$44,000
0.0% of portfolio
391
Q3 2024
Added 42.18%
$307M
$2,000
0.0% of portfolio
88
Q3 2024
Added 1.15%
$10.2B
$76,000
0.0% of portfolio
884
Q3 2024
Reduced 38.4%
-
$0
0.0% of portfolio
-
Q3 2024
Added 29.39%
$425M
$0
0.0% of portfolio
100
Q3 2024
New
$1.83B
$28,000
0.0% of portfolio
999
Q3 2024
Reduced 0.1%
$3.22B
$0
0.0% of portfolio
1
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 27.77%
$1.55B
$6,000
0.0% of portfolio
383
Q3 2024
New
$573M
$139,000
0.0% of portfolio
55,506
Q3 2024
Added 7.02%
$125B
$3.31 Million
0.0% of portfolio
52,864
Q3 2024
Reduced 85.68%
$4.29B
$34,000
0.0% of portfolio
1,748
Q3 2024
New
$0
$302,000
0.0% of portfolio
6,060
Q3 2024
Added 0.95%
60 Degrees Pharmaceuticals I
-
$0
0.0% of portfolio
-
Q3 2024
New
$5.86B
$35,000
0.0% of portfolio
2,035
Q3 2024
Reduced 99.35%
$0
$37,000
0.0% of portfolio
285
Q2 2024
Reduced 54.11%
$541M
$82,000
0.0% of portfolio
360
Q2 2023
Reduced 30.77%
$0
$346,000
0.0% of portfolio
3,630
Q3 2024
Added 0.83%
$57.5B
$416,000
0.0% of portfolio
22,900
Q3 2024
Reduced 8.11%
$29.5B
$19,000
0.0% of portfolio
1,201
Q3 2024
Added 0.08%
$0
$14,000
0.0% of portfolio
43
Q4 2021
New
$0
$3.03 Million
0.0% of portfolio
79,657
Q3 2024
Added 1.27%
-
$0
0.0% of portfolio
-
Q1 2023
New